Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate

Esther M. M. van de Glind; Hanna C. Willems; Saeid Eslami; Ameen Abu-Hanna; Willem F. Lems; Lotty Hooft; Sophia E. de Rooij; Dennis M. Black; Barbara C. van Munster

doi:10.1007/s40266-016-0344-7

Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate

Esther M. M. van de Glind, Hanna C. Willems, Saeid Eslami, Ameen Abu-Hanna, Willem F. Lems, Lotty Hooft, Sophia E. de Rooij, Dennis M. Black, Barbara C. van Munster

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	347-353
Journal	Drugs & Aging
Volume	33
Issue number	5
DOIs	https://doi.org/10.1007/s40266-016-0344-7
Publication status	Published - May 2016

Access to Document

10.1007/s40266-016-0344-7

Cite this

@article{b5bd9b07391c4eb99e1d5d3161bd03bc,

title = "Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate",

author = "{van de Glind}, {Esther M. M.} and Willems, {Hanna C.} and Saeid Eslami and Ameen Abu-Hanna and Lems, {Willem F.} and Lotty Hooft and {de Rooij}, {Sophia E.} and Black, {Dennis M.} and {van Munster}, {Barbara C.}",

year = "2016",

month = may,

doi = "10.1007/s40266-016-0344-7",

language = "English",

volume = "33",

pages = "347--353",

journal = "Drugs & Aging",

issn = "1170-229X",

publisher = "Adis International Ltd",

number = "5",

}

TY - JOUR

T1 - Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate

AU - van de Glind, Esther M. M.

AU - Willems, Hanna C.

AU - Eslami, Saeid

AU - Abu-Hanna, Ameen

AU - Lems, Willem F.

AU - Hooft, Lotty

AU - de Rooij, Sophia E.

AU - Black, Dennis M.

AU - van Munster, Barbara C.

PY - 2016/5

Y1 - 2016/5

U2 - 10.1007/s40266-016-0344-7

DO - 10.1007/s40266-016-0344-7

M3 - Article

C2 - 26884390

VL - 33

SP - 347

EP - 353

JO - Drugs & Aging

JF - Drugs & Aging

SN - 1170-229X

IS - 5

ER -